Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
Baxter Suspends Heparin Production

February 15, 2008
Baxter International, Inc. has temporarily suspended production of heparin, a blood-thinner, due to reports of allergic reactions, including four deaths, primarily in patients undergoing kidney dialysis and heart surgery. Heparin, a generic drug, is…  Read More »
Southern Research Institute

February 15, 2008
Wilson Blaine Knight, Ph.D., a former executive with GlaxoSmithKline, has been named vice president of Southern Research Institute's Drug Discovery Division.      “We are very pleased that Dr. Knight has joined us to lead…  Read More »
Patheon, Inc.

February 14, 2008
Terry Novak has been appointed president, North American Operations and chief marketing officer, effective February 18, 2008, Patheon Inc. Mr. Novak will be responsible for managing and growing the company's North American commercial manufacturing op…  Read More »
Quintiles Central Lab in India Gets CAP Certification

February 14, 2008
The College of American Pathologists (CAP) has certified Quintiles Transnational Corp.'s central lab in Mumbai, India. The lab began supporting clinical trials in 1Q2007. Since then, the facility has been adding to its services and analytical capabil…  Read More »
Laureate Pharma

February 14, 2008
Gary Swan has been appointed vice president of operations, Laureate Pharma, Inc. In this newly created position, Mr. Swan will be responsible for leading the company's manufacturing operations, which include upstream and downstream processing, formul…  Read More »
Biogen Idec, Cardiokine Begin Phase III CHF Trial

February 14, 2008
Biogen Idec and Cardiokine, Inc. initiated a Phase III study of lixivaptan for congestive heart failure patients who suffer from hyponatremia, which is an electrolyte disturbance marked by low sodium levels in the blood. The trial will compare treatm…  Read More »
Financial Report: Genzyme

February 13, 2008
Genzyme 4Q Revenues: $1.0 billion (+21%) 4Q Earnings: $78.9 million (loss of $268.2 million 4Q06) FY Revenues: $3.8 billion (+20%) FY Earnings: $480.2 million (loss of $16.8 million FY06) Comments: Revenue growth was driven by strong sales of it…  Read More »
Metrics Expands Lab Space

February 13, 2008
Metrics Inc. has opened its newest analytical lab space. The four new analytical labs add to the company’s capacity for service by 40%. The labs will be fully operational and validated by 2Q 2008.      “We have been…  Read More »
Financial Report: Schering-Plough

February 12, 2008
Schering-Plough 4Q Revenues: $3.7 billion (+41%)   4Q Loss: $3.3 billion (earnings were $204 million in 4Q06) FY Revenues: $12.7 billion (+20%) FY Loss: $1.5 billion (earnings were $1.1 billion FY06) Comments: Global pharmaceutical…  Read More »
Financial Report: Catalent Pharma Solutions

February 12, 2008
Catalent Pharma Solutions 2Q Revenues: $464 million (+11%) 2Q Loss: $30.2 million (earnings were $18.5 million 4Q06) YTD Revenues: $902 million (+11%) YTD Loss: $41.5 million (earnings were $19.6 million YTD06) Comments: Revenue growt…  Read More »
ICON Acquires Healthcare Discoveries

February 12, 2008
ICON has acquired Healthcare Discoveries, Inc., a wholly owned subsidiary of Catalyst Pharma Group, Inc., for $12 million in cash, and if certain performance milestones are achieved in 2008, a further consideration of as much as $10 million. Healthca…  Read More »
Schering-Plough

February 11, 2008
Schering-Plough Corp. has made leadership and organizational changes at Schering-Plough Research Institute (SPRI), the R&D arm of the company.     Jacqueline Elbonne, Ph.D., has been named vice president, global research quality…  Read More »
Financial Report: AMRI

February 11, 2008
AMRI 4Q Revenues: $47.2 million (+1%) 4Q Loss: $844,000 (loss of $764,000 in 4Q2006) FY Revenues: $192.5 million (+7%) FY Earnings: $8.9 million (earnings were $2.2 million FY2006) Comments: Total contract and milestone revenue for th…  Read More »
Merck To Pay $671 Million in Fraud Settlement

February 8, 2008
Merck has agreed to pay more than $671 million to settle allegations of fraud concerning Medicaid and other public healthcare programs across the U.S., according to a federal Settlement Agreement. According to qui tam lawyers Steven H. Cohen, Mark Kl…  Read More »
Financial Report: GlaxoSmithKline

February 8, 2008
GlaxoSmithKline 4Q Revenues: $12.1 billion (+5%) 4Q Earnings: $2.2 billion (-6%) FY Revenues: $45.4 billion (+6%) FY Earnings: $10.6 billion (+4%)   Comments: Advair sales were $7.0 billion for the year (+15%) and $1.9 billion in…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: